DORAL, Florida, June 27, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative
biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and
development, signs agreement to work collectively with AATAC to present the “ETST” product line to their vast network of
approximately 90,000 retail outlets throughout the U.S.
AATAC will be introducing the Company’s High Grade Full Spectrum Cannabinoids line within its 90,000 outlet reach. The Company
has sent AATAC’s operations and distribution teams it’s current batch line to help pave the way to it’s large new batch currently
being formulated and packaged. Coupled with the growing consumer interest in the category and positive feedback received from their
network, AATAC anticipates a high volume of preorders once an official release date is set.
The Company’s Chief Sales Officer, Jill Buzan stated, “Our association with AATEC which is an advisory board that focuses
on convenience stores will give us the opportunity to open up and be available to a market that includes every sector of the
population. This could lead to huge exponential growth for ETST’s sales in the next few months.”
Gagan Hunter, the Company’s COO & Director states, “We had some delays finding a new reliable source and manufacturing plant
but, it was worth the wait. We found a new manufacture with a better turn around time and a source with a consistent true full
spectrum having all the cannabinoids as our previous batch with higher concentration. We strive on providing consistent and
reliable source of cannabinoids to our customers. We anticipate on having our new large batch to have enough supply for our rising
demand within the next several weeks. Also we are working on a three new chocolate skus and we plan on a new product announcement
soon.”
The Company plans on sharing further updates on the new inventory batch, research & development, Form 10 approval, and medical
device updates as they progress.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market.
There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies
through DV Biologics proved it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key
health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most
effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com
ETST currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and
expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
Earth Science Pharmaceutical
Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc.
("ESP"), which is committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and
vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer Dr. Michel Aubé is leading the
company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of
STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices
and vaccines that meet the specific needs of women.
To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics
Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”),
which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and
nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The
company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and
ovarian cancers, as well as two generic CBD based pharmaceutical drugs.
To learn more please visit: www.CannabisThera.com
KannaBidioiD
KannaBidioid, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) provides a wide
variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and
distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal
relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
To learn more please visit: www.KannaBidioiDInc.com
Earth Science Foundation, Inc.
Earth Science Foundation, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc.
("ESF"), is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help
donate Earth Science Tech, Inc's effective CBD products to those in need.
To learn more please visit: www.ETSTFoundtion.org
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and
Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position,
results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth
opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe,"
"plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking
statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual
results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no
obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result
of new information, future events or otherwise.
Investor Relations Contact: Dave Demarest 305.546.7640 Office Company Contact: www.EarthScienceTech.com Nickolas S. Tabraue President & Director 305.615.2118
